Apr 26, 2007 by Ryan FuhrmannTractor Supply Gears UpThe stock isn't cheap, but the growth prospects could make Tractor Supply worth a look.
Apr 25, 2007 by Ryan FuhrmannA Tale of Two CheesecakesCheesecake Factory's newer concept is currently helping offset namesake weakness.
Apr 25, 2007 by Ryan FuhrmannIs Aflac a Lame Duck?Aflac is struggling in Japan, but its home market is wide open.
Apr 24, 2007 by Ryan FuhrmannEarnings-eluting Time at Boston Scientific: Fool by NumbersFast facts the Fool way.
Apr 24, 2007 by Ryan FuhrmannBoston Scientific Regains ConsciousnessRecent Boston Scientific results show glimmers of hope.
Apr 24, 2007 by Ryan FuhrmannWill Snap-on Ever Slow Down?The company is doing well, but at what cost to prospective investors?
Apr 24, 2007 by Ryan FuhrmannRed and White Results at AmgenAt current levels, Amgen could be worth a further look.
Apr 24, 2007 by Ryan FuhrmannMixed Foliage at Forest LabsHere's what to look for as Forest Labs prepares for a big loss.
Apr 23, 2007 by Ryan FuhrmannThe Coast Is Clear at AllstateInsurance is risky, but Allstate is one of the most dependable operators.
Apr 20, 2007 by Ryan FuhrmannDiscerning Pfizer's PfutureThe company is undergoing a transformation, but that doesn't mean it isn't worth a look.
Apr 20, 2007 by Ryan FuhrmannDiagnosing Quest DiagnosticsQuest should recover from a recent, painful contract loss.
Apr 20, 2007 by Ryan FuhrmannHousing Woes Stain Sherwin-WilliamsDespite the housing slump, the paint firm's stock has held up surprisingly well.
Apr 19, 2007 by Ryan FuhrmannQuest Diagnostics Becomes Un-United: Fool by NumbersFast facts the Fool way.
Apr 19, 2007 by Ryan FuhrmannKeyCorp's Key ConcernKeyCorp has investment appeal, but not enough to set it apart from the competition.
